CoChat

Mifepristone or inhibition of 11β-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Δ(9)-tetrahydrocannabinol in mice

Pryce, Gareth, Giovannoni, Gavin, Baker, David · 2003 · Neuroscience Letters

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

The cannabinoid system is a regulator of neurotransmission and is linked with hormonal control. We have found in experimental mouse studies that the progesterone receptor inhibitor mifepristone (RU38486, 80 mg/kg i.p.) or the 11beta-hydroxylase inhibitor metyrapone (100 mg/kg i.p.) when administered in combination with cannabinoids potentiates the transient-sedating cannabinoid receptor-1 effects of a high-dose Delta(9)-tetrahydrocannabinol (25 mg/kg i.p.), causing severe prolonged sedation associated with hypomotility, catalepsy and hypothermia. This observation has implications for human subjects taking these drugs and related compounds particularly because of the ubiquitous use of cannabis and the high potential for mifepristone and related compounds to become available on the 'black-market' as abortifacients.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0304-3940(03)00159-9

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 8 references

Research works printed but not linked: 1

  1. Baker, 2001, Cannabinoid-mediated treatment of autoimmune disease of the CNS and eye, J. Neuroimmunol., 118, 55

Cited by

See all 22

Metadata

Authors
Pryce, G., Giovannoni, G., & Baker, D.
Affiliations
National Hospital for Neurology and Neurosurgery (GB)
Corresponding author
Giovannoni, Gavin
Venue
Neuroscience Letters
Publisher
Elsevier BV
Published
2003-05
Volume
341
Issue
2
Pages
164-166
ISSN
0304-3940 (ISSN-L)
OpenAlex
W1986048570
Cited by
22
References
8
Citations by year
2023: 1 · 2021: 3 · 2017: 1 · 2015: 1 · 2014: 1 · 2012: 3
FWCI
0.64
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Neuroscience Letters (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Multiple Sclerosis Society
  • National Institute on Drug Abuse
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
mifepristone, metyrapone, 11β-hydroxylase inhibition, progesterone receptor, CB1 receptor, delta-9-tetrahydrocannabinol, drug potentiation, sedation, catalepsy, hypothermia, hypomotility, cannabis
MeSH terms
Animals, Body Temperature Regulation, Drug Synergism, Enzyme Inhibitors, Hormone Antagonists, Male, Metyrapone, Receptors, Drug, Dronabinol, Time Factors, Mifepristone, Procedural Sedation, Analgesics, Non-Narcotic, Receptors, Cannabinoid, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mifepristone or inhibition of 11β-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Δ(9)-tetrahydrocannabinol in mice. https://app.cochat.ai/papers/10.1016/s0304-3940(03)00159-9
The paper
Pryce, G., Giovannoni, G., & Baker, D. (2003). Mifepristone or inhibition of 11β-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Δ(9)-tetrahydrocannabinol in mice. Neuroscience Letters. https://doi.org/10.1016/s0304-3940(03)00159-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.